US cancer centers begin enrolling patients into the global, randomized Phase II study of roginolisib in metastatic uveal melanoma Dana-Farber Cancer Institute launches new trial of roginolisib for Chronic Lymphocytic Leukemia, backed by Department of Defense grant GENEVA, AMSTERDAM and…
